Search

Your search keyword '"Nemecek, E"' showing total 125 results

Search Constraints

Start Over You searched for: Author "Nemecek, E" Remove constraint Author: "Nemecek, E"
125 results on '"Nemecek, E"'

Search Results

2. Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

4. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

5. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

8. S112: TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL): FINAL ANALYSES FROM THE ELIANA STUDY

13. S1618 TISAGENLECLEUCEL APPEARS EFFECTIVE AND SAFE IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA WITH HIGH-RISK CYTOGENETIC ABNORMALITIES

14. Evolocumab and clinical outcomes in patients with cardiovascular disease

15. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

16. Evolocumab and clinical outcomes in patients with cardiovascular disease

20. Intra-operative ultrasound facilitates significantly the localisation of the lime deposit during arthroscopic treatment of calcifying tendinits: a prospective randomized study

25. Nonmyeloablative Conditioning Followed by Allogeneic Marrow Grafts for Treatment of Primary Immune Deficiency Disorders: Preliminary Results of a Phase II Study

26. Poster session I * Thursday 9 December 2010, 08:30-12:30

27. Postgrafting Immune Suppression Combined With Nonmyeloablative Conditioning For Transplantation Of HLA-Matched Related Or Unrelated Hematopoetic Cell Grafts: Preliminary Results Of A Phase II Study For Treatment Of Primary Immunodeficiency Disorders

35. Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial

36. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

37. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

38. Proceedings of the 2024 Third Annual ASTCT-NMDP ACCESS Initiative Workshop.

39. Broström ankle ligament repair augmented with suture tape : Results of magnetic resonance imaging evaluation.

40. LNK/ SH2B3 as a novel driver in juvenile myelomonocytic leukemia.

41. CAR T-Cell Immunotherapy in Minority Patients with Lymphoma.

42. Dexmedetomidine Utilization During Air Medical Transport for Agitated Patients.

43. Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop.

44. Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial.

46. The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem.

47. Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

48. Prolonged hematologic toxicity following treatment with chimeric antigen receptor T cells in patients with hematologic malignancies.

50. Recombinant Human BMP6 Applied Within Autologous Blood Coagulum Accelerates Bone Healing: Randomized Controlled Trial in High Tibial Osteotomy Patients.

Catalog

Books, media, physical & digital resources